ReviewJournal for immunotherapy of cancer2018

Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance.

Michael M Boyiadzis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.